Uni-Bio Science Group Limited (00690.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 0.07

From 52W high−55.90%

Volume60000.00

Market capHKD 425.31M

P/E (TTM)—

P/S (TTM)0.8x

Div yield4.41%

Key dataSep 18, 2026

Open

HKD 0.07

From 52W high

−55.90%

Volume

60000.00

Market cap

HKD 425.31M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.2x

P/E (TTM)

—

RSI (14)

55.9

MomentumView details →

1D Return

−2.74%

YTD Return

−38.26%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

5.2x

EV/Sales

0.6x

P/S (TTM)

0.8x

P/B (TTM)

0.9x

ProfitabilityView details →

Gross Margin

82.71%

Net Margin

8.83%

EBITDA Margin

12.38%

ROE (TTM)

10.82%

ROA (TTM)

8.02%

Asset Turnover

0.93x

GrowthView details →

Revenue YoY

−6.75%

EPS YoY

−46.71%

FCF YoY

—

Revenue CAGR 3Y

+10.01%

EPS CAGR 3Y

+36.75%

EBITDA YoY

−44.29%

MomentumView details →

1D Return

−2.74%

YTD Return

−38.26%

1Y Return

−53.29%

RSI (14)

55.9

vs 50D SMA

+1.37%

vs 200D SMA

−25.64%

Capital & dividendView details →

Debt/Equity

0.19x

Current Ratio

2.93x

Quick Ratio

2.55x

Div Yield

4.41%

Div Rate

HKD 0.00

Div Growth 1Y

+13.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.14B

Net Income (TTM)

139.89M

Op. CF (TTM)

114.40M

Latest newsMore news →

Uni-Bio Science Group Limited announced its interim results for the six months ended 30 June 2026, reporting revenue of approximately HK$273.8 million and net profit of approximately HK$31.2 million.25d ago

Similar companies

Zura Bio LimitedZURA Atea Pharmaceuticals, Inc.AVIR PureTech Health plcPRTC Artiva Biotherapeutics, Inc.ARTV Opus Genetics, Inc.IRD Cabaletta Bio, Inc.CABA Find similar companies →

Latest newsMore news →

Uni-Bio Science Group Limited announced its interim results for the six months ended 30 June 2026, reporting revenue of approximately HK$273.8 million and net profit of approximately HK$31.2 million.25d ago